Enforcement Report - Week of February 2, 2022
FARMABIOS S.P.A Fails EDQM Inspection
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products
Recipharm Ltd. Fails EDQM Inspection
Teligent Pharma Inc.’s Generic Hydrocortisone Receives Approval In The US
Diurnal`s Alkindi (Hydrocortisone) Receives Approval In Europe